![Steve Cartt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steve Cartt
Direktor/Vorstandsmitglied bei
Neurelis, Inc.
Profil
Stephen Lahue Cartt is currently a Director at Neurelis, Inc. He was previously a Director at Lineage Cell Therapeutics, Inc., a Senior Director-Strategic Marketing at Elan Pharmaceuticals, LLC, a Director at Asterias Biotherapeutics, Inc., a Director at TXP Pharma AG (Switzerland), a Principal at ALZA Corp., the Chief Operating Officer at Questcor Pharmaceuticals, Inc., and the COO-Autoimmune & Rare Diseases Business Unit at Mallinckrodt Plc.
He holds an MBA from Santa Clara University and an undergraduate degree from the University of California, Davis.
Aktive Positionen von Steve Cartt
| Unternehmen | Position | Beginn |
|---|---|---|
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Steve Cartt
| Unternehmen | Position | Ende |
|---|---|---|
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Direktor/Vorstandsmitglied | 01.01.2023 |
| ASTERIAS BIOTHERAPEUTICS INC | Vorstandsvorsitzender | 25.06.2017 |
| LINEAGE CELL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.02.2016 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.10.2014 |
| QUESTCOR PHARMACEUTICALS INC | Geschäftsführer | 01.08.2014 |
Ausbildung von Steve Cartt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Health Technology |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases | Health Technology |
